Indo Borax Board Approves ₹40 Dividend, FY26 Results
Indo Borax & Chemicals Limited's Board approved audited financial results for FY26. The company recommended a final dividend of ₹10 and a special dividend of ₹30 per share, totaling ₹40, subject to shareholder approval at the AGM. Internal and Cost Auditors were also appointed.
The dividend announcement and approval of financial results are material information for investors, impacting investment decisions and shareholder value.
The announcement of financial results along with a significant dividend payout (₹40 per share) is positive for shareholders.
Indo Borax & Chemicals Limited announced the outcome of its Board Meeting held on Thursday, May 21, 2026. The Board has approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
The company reported a final dividend of ₹10 per equity share (1000%) and a special dividend of ₹30 per equity share (3000%) for the financial year 2025-26. These dividends are subject to shareholder approval at the upcoming 45th Annual General Meeting (AGM).
The Board also approved the re-appointment of M/s. V. B. Modi & Associates as Cost Auditor for FY 2026-27, subject to shareholder ratification of remuneration at the AGM. Additionally, M/s. Shah Kapadia & Associates have been appointed as the Internal Auditor for FY 2026-27. The Nomination and Remuneration Committee (NRC) composition was also re-constituted.
The financial results, including the statement of assets and liabilities as of March 31, 2026, and the cash flow statement for the financial year ended March 31, 2026, are available on the company's website, www.indoborax.com, and the websites of BSE Ltd and the National Stock Exchange of India Ltd. The statutory auditors have issued an unmodified audit opinion on the financial results.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.